US: Cigna And Aetna spent more than $1.3M on outside lobbying for mergers In 2015
The frenzied year of deal making that was 2015 saw, among other moves, Aetna agree in July to buy Humana for $34.1 billion, a deal which remains subject to approval by antitrust regulators. That same month, Anthem also agreed to buy Cigna for $48.4 billion, a deal that also requires regulatory approval from the Justice Department’s Antitrust Division. Where those reviews could lead and when they would be finalized remain uncertain, two questions that have sparked speculation among experts.
Featured News
Paramount Seeks to Address Regulatory Concerns Over Warner Bros. Discovery Deal
Jun 8, 2026 by
CPI
Italy Ends Meta WhatsApp AI Probe as EU Investigation Expands
Jun 8, 2026 by
CPI
Both Left and Right in Washington Eye Public Equity Stakes in AI Companies
Jun 8, 2026 by
CPI
Democrats Roll Out Wave of AI Bills as Voter Concerns Mount
Jun 8, 2026 by
CPI
House Judiciary Committee Report Accuses NFL of Misusing Antitrust Exemption
Jun 8, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – (Geo)Political Antitrust
May 28, 2026 by
CPI
Competition Policy in Turbulent Geopolitical Times
May 28, 2026 by
Christophe Carugati & Annabelle Gawer
The New Political Determinants of U.S. Antitrust Policy
May 28, 2026 by
Aziz Z. Huq
The Geopolitical Rewiring of Antitrust
May 28, 2026 by
Hayane C. Dahmen
Three Strikes Against Political Antitrust
May 28, 2026 by
Nolan McCarty & Sepehr Shahshahani